Open Access
Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family
Robert M Pitti
1
,
SCOT A. MARSTERS
1
,
SIEGFRIED RUPPERT
2
,
Christopher J Donahue
3
,
Alison Moore
4
,
Avi Ashkenazi
1
1
Departments of Molecular Oncology, Genentech, Inc., South San Francisco, California 94080-4990
|
2
Departments of Molecular Biology, Genentech, Inc., South San Francisco, California 94080-4990
|
3
Departments of Immunology, and Genentech, Inc., South San Francisco, California 94080-4990
|
4
Departments of Cell Biology, Genentech, Inc., South San Francisco, California 94080-4990
|
Publication type: Journal Article
Publication date: 1996-05-01
scimago Q1
wos Q2
SJR: 1.705
CiteScore: 7.6
Impact factor: 3.9
ISSN: 00219258, 1083351X
PubMed ID:
8663110
Biochemistry
Molecular Biology
Cell Biology
Abstract
Cytokines in the tumor necrosis factor (TNF) family regulate development and function of the immune system. We have isolated a new member of this family, designated Apo-2 ligand (Apo-2L), via an expressed sequence tag. Apo-2L is a 281-amino acid protein, related most closely to Fas/Apo-1 ligand. Transfected Apo-2L is expressed at the cell surface with its C terminus exposed, indicating a type II transmembrane protein topology. Like Fas/Apo-1 ligand and TNF, the C-terminal extracellular region of Apo-2L (amino acids 114-281) exhibits a homotrimeric subunit structure. Soluble Apo-2L induces extensive apoptosis in lymphoid as well as non-lymphoid tumor cell lines. The effect of Apo-2L is not inhibited by soluble Fas/Apo-1 and TNF receptors; moreover, expression of human Fas/Apo-1 in mouse fibroblasts, which confers sensitivity to induction of apoptosis by agonistic anti-Fas/Apo-1 antibody, does not confer sensitivity to Apo-2L. Hence, Apo-2L acts via a receptor which is distinct from Fas/Apo-1 and TNF receptors. These results suggest that, along with other family members such as Fas/Apo-1 ligand and TNF, Apo-2L may serve as an extracellular signal that triggers programmed cell death.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
5
10
15
20
25
30
35
40
45
50
|
|
|
Journal of Biological Chemistry
47 publications, 3.27%
|
|
|
Journal of Immunology
41 publications, 2.85%
|
|
|
Oncogene
39 publications, 2.71%
|
|
|
Biochemical and Biophysical Research Communications
24 publications, 1.67%
|
|
|
Blood
24 publications, 1.67%
|
|
|
Cell Death and Differentiation
22 publications, 1.53%
|
|
|
Cancer Research
20 publications, 1.39%
|
|
|
Cancer Letters
17 publications, 1.18%
|
|
|
Oncotarget
16 publications, 1.11%
|
|
|
Molecular Cancer Therapeutics
16 publications, 1.11%
|
|
|
British Journal of Cancer
15 publications, 1.04%
|
|
|
PLoS ONE
14 publications, 0.97%
|
|
|
Cell Death and Disease
13 publications, 0.9%
|
|
|
Cancers
13 publications, 0.9%
|
|
|
International Journal of Molecular Sciences
13 publications, 0.9%
|
|
|
Cancer Gene Therapy
13 publications, 0.9%
|
|
|
International Journal of Cancer
13 publications, 0.9%
|
|
|
Vitamins and Hormones
13 publications, 0.9%
|
|
|
Clinical Cancer Research
13 publications, 0.9%
|
|
|
Journal of Experimental Medicine
12 publications, 0.84%
|
|
|
Journal of Cellular Biochemistry
11 publications, 0.77%
|
|
|
FEBS Letters
10 publications, 0.7%
|
|
|
Oncology Reports
9 publications, 0.63%
|
|
|
Cell Research
9 publications, 0.63%
|
|
|
Apoptosis : an international journal on programmed cell death
9 publications, 0.63%
|
|
|
Cancer Biology and Therapy
9 publications, 0.63%
|
|
|
Current Biology
8 publications, 0.56%
|
|
|
Immunity
8 publications, 0.56%
|
|
|
Scientific Reports
8 publications, 0.56%
|
|
|
5
10
15
20
25
30
35
40
45
50
|
Publishers
|
50
100
150
200
250
300
350
|
|
|
Elsevier
345 publications, 24.01%
|
|
|
Springer Nature
305 publications, 21.22%
|
|
|
Wiley
168 publications, 11.69%
|
|
|
American Association for Cancer Research (AACR)
58 publications, 4.04%
|
|
|
Taylor & Francis
55 publications, 3.83%
|
|
|
MDPI
50 publications, 3.48%
|
|
|
American Society for Biochemistry and Molecular Biology
47 publications, 3.27%
|
|
|
The American Association of Immunologists
42 publications, 2.92%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
26 publications, 1.81%
|
|
|
American Society of Hematology
24 publications, 1.67%
|
|
|
Spandidos Publications
23 publications, 1.6%
|
|
|
Mary Ann Liebert
17 publications, 1.18%
|
|
|
Impact Journals
16 publications, 1.11%
|
|
|
SAGE
15 publications, 1.04%
|
|
|
Public Library of Science (PLoS)
14 publications, 0.97%
|
|
|
Frontiers Media S.A.
14 publications, 0.97%
|
|
|
Rockefeller University Press
13 publications, 0.9%
|
|
|
American Society for Microbiology
12 publications, 0.84%
|
|
|
American Chemical Society (ACS)
10 publications, 0.7%
|
|
|
Oxford University Press
10 publications, 0.7%
|
|
|
S. Karger AG
8 publications, 0.56%
|
|
|
Hindawi Limited
8 publications, 0.56%
|
|
|
American Association for the Advancement of Science (AAAS)
7 publications, 0.49%
|
|
|
IMR Press
7 publications, 0.49%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
5 publications, 0.35%
|
|
|
Royal Society of Chemistry (RSC)
5 publications, 0.35%
|
|
|
American Society of Clinical Oncology (ASCO)
5 publications, 0.35%
|
|
|
Portland Press
4 publications, 0.28%
|
|
|
Journal of Neurosurgery Publishing Group (JNSPG)
4 publications, 0.28%
|
|
|
50
100
150
200
250
300
350
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1.4k
Total citations:
1437
Citations from 2024:
36
(2.5%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Pitti R. M. et al. Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family // Journal of Biological Chemistry. 1996. Vol. 271. No. 22. pp. 12687-12690.
GOST all authors (up to 50)
Copy
Pitti R. M., MARSTERS S. A., RUPPERT S., Donahue C. J., Moore A., Ashkenazi A. Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family // Journal of Biological Chemistry. 1996. Vol. 271. No. 22. pp. 12687-12690.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1074/jbc.271.22.12687
UR - https://doi.org/10.1074/jbc.271.22.12687
TI - Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family
T2 - Journal of Biological Chemistry
AU - Pitti, Robert M
AU - MARSTERS, SCOT A.
AU - RUPPERT, SIEGFRIED
AU - Donahue, Christopher J
AU - Moore, Alison
AU - Ashkenazi, Avi
PY - 1996
DA - 1996/05/01
PB - American Society for Biochemistry and Molecular Biology
SP - 12687-12690
IS - 22
VL - 271
PMID - 8663110
SN - 0021-9258
SN - 1083-351X
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{1996_Pitti,
author = {Robert M Pitti and SCOT A. MARSTERS and SIEGFRIED RUPPERT and Christopher J Donahue and Alison Moore and Avi Ashkenazi},
title = {Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family},
journal = {Journal of Biological Chemistry},
year = {1996},
volume = {271},
publisher = {American Society for Biochemistry and Molecular Biology},
month = {may},
url = {https://doi.org/10.1074/jbc.271.22.12687},
number = {22},
pages = {12687--12690},
doi = {10.1074/jbc.271.22.12687}
}
Cite this
MLA
Copy
Pitti, Robert M., et al. “Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family.” Journal of Biological Chemistry, vol. 271, no. 22, May. 1996, pp. 12687-12690. https://doi.org/10.1074/jbc.271.22.12687.